<DOC>
	<DOCNO>NCT02381184</DOCNO>
	<brief_summary>One hundred thirty six anovulatory woman CC-resistant PCOS schedule randomly two equal group . Group A ( n=68 ) ; receive CC ( 100 mg/day cycle day 3 10 day ) six cycle . Group B ( n=68 ) underwent LOD follow 6 month . The primary outcome ovulation rate group ; secondary outcome midcycle endometrial thickness serum estradiol , midluteal serum progesterone , rate clinical pregnancy abortion .</brief_summary>
	<brief_title>Extended Clomiphene Citrate Regimen Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>This prospective randomize trial include 136 anovulatory woman CC-resistant PCOS among attend Gynecology Outpatient Clinics , Benha University Hospital , private practice setting , Alkalubia , Egypt August 2012 August 2014 . The study protocol approve Local Ethics Committee write informed consent obtain study commence . Diagnosis PCOS base Rotterdam criterion ( 18 ) , whereby diagnosis PCOS require presence two three criterion exclusion etiology , i.e. , oligomenorrhea and/or anovulation , clinical and/or biochemical sign hyperandrogenism , and/or polycystic ovary ultrasound . Inclusion criterion : 1- Age : 18-35 year . 2- Period infertility &gt; 2 year . 3- Serum level FSH &lt; 10 U/L early follicular phase . 4- All woman CC-resistant PCOS , fail ovulate dose CC 150 mg/day 5 day per cycle least three consecutive cycle . 5- All woman patent Fallopian tube prove hysterosalpingography laparoscopy partner satisfy normal parameter semen analysis accord modify WHO criterion ( 19 ) . Exclusion criterion : 1- Infertility due cause CC- resistant PCOS due combine factor . 2- Body mass index ( BMI ) ≥35 Kg/m² . 3- The use metformin , gonadotropin , hormonal contraception diet regimen within last 6 month . 4- Women congenital adrenal hyperplasia , hyperprolactinaemia abnormal thyroid function . 5- Hypersensitivity contraindication Letrozole clomiphene treatment . 6- Previous LOD . The study start two month last CC treatment cycle eliminate post-treatment effect CC . At admission , thorough evaluation participant carry via history take physical examination , include anthropometric measurement . A baseline transvaginal ultrasound examination do use 7-10 MHZ probe ( Voluson 730 PRO V , GE Healthcare , USA ) measure endometrial thickness exclude pelvic pathology treatment . Basal hormonal assay perform day 3 spontaneous progestin induced cycle include measurement serum concentration luteinizing hormone ( LH ) , follicle-stimulating hormone ( FSH ) , testosterone . Randomization do accord computer generate random numerical table two equal group . Treatment allocation conceal use sequentially number opaque seal envelope . Envelopes open consecutively third person ( study nurse ) , assign patient extended Clomiphene Citrate group ( Group A ) LOD group ( Group B ) . Once allocate , treatment reveal investigator patient . Group A ( n =68 ) assign receive100 mg clomiphene citrate ( Clomid® ; Hoechst Marion Russel , Cairo , Egypt ) daily start day 3 spontaneous progestin induce cycle 10 day . Group B ( n =68 ) underwent LOD . Laparoscopy perform general anesthesia , use three-puncture technique . Each ovary cauterize perpendicular antimesenteric border four point , 4 second 40 W mixed current , use monopolar electrosurgical needle ( Karl Storz , ND , Germany ) . Each puncture 4 mm diameter 6-8 mm depth . The ovary cooled irrigation normal saline solution . Any , intraoperative postoperative complication report . The follow-up start next cycle ovarian drill 6 month . Starting cycle day 9 , ultrasound scan repeat daily monitor follicle growth ( number mean diameter ) . Ultrasound examination do doctor avoid interobserver variability blind treatment group . When optimal follicle size reach ( i.e . mean follicular diameter ≥ 18 mm ) , HCG 10,000 IU ( Epifasi , EPICO , Egypt ) give intramuscular trigger ovulation . No HCG give protect sexual intercourse advise , ≥ 3 follicle diameter ≥16mm avoid risk ovarian hyperstimulation syndrome multiple gestation . Intrauterine insemination perform 36 - 40 hour HCG injection use soft tip catheter . Serum E2 endometrial thickness measure day HCG administration . The endometrial thickness measure sagittal plane fundus uterus ( point maximal thickness ) echogenic interface junction endometrium myometrium Ovulation confirm midluteal ( day 21of cycle ) serum progesterone ≥ 5 ng/mL . Serum β-hCG determine 2 week HCG injection diagnosis biochemical pregnancy . Sonographic evidence intrauterine gestational sac 6 week gestation consider evident clinical pregnancy . Treatment continue six month . Patients counsel line treatment ovulation confirm midluteal serum progesterone level le 5 ng /ml within 3 month . The primary outcome ovulation rate group . Secondary outcome endometrial thickness serum estradiol ( pg/ml ) , day hCG injection , midluteal serum progesterone ( ng/ml ) rate clinical pregnancy first trimester spontaneous abortion . The ovulation rate calculate percentage ovulatory cycle per total observed cycle . The cumulative pregnancy rate define number pregnant patient total number patient . The abortion rate define percentage miscarriage first 12 week gestation per total pregnancy , biochemical miscarriage consider pregnancy loss occur confirmed biochemical pregnancy without ultrasound evidence intrauterine pregnancy .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Age : 1835 year Period infertility &gt; 2 year Serum level FSH &lt; 10 U/L early follicular phase All woman CCresistant PCOS , fail ovulate dose CC 150 mg/day 5 day per cycle least three consecutive cycle All woman patent Fallopian tube prove hysterosalpingography laparoscopy partner satisfy normal parameter semen analysis accord modify WHO criteria Infertility due cause CC resistant PCOS due combine factor Body mass index ( BMI ) ≥35 Kg/m² The use metformin , gonadotropin , hormonal contraception diet regimen within last 6 month Women congenital adrenal hyperplasia , hyperprolactinaemia abnormal thyroid function Hypersensitivity contraindication Letrozole clomiphene treatment Previous LOD</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>